Able Partners

augmenta ventures exists to redefine the possibilities of human potential through strategic investments in innovative technologies and inclusive solutions. Our commitment is encapsulated in our mission: "Investing in and Building the Future of Human Potential." By focusing on key sectors that impact society, we aim to unlock growth opportunities and empower individuals globally. This white paper explores our approach to addressing some of the most pressing global challenges through innovation, technology, and a carefully designed investment strategy. Through augmenta ventures, we co-invest in ventures enhancing life for people with limitations, from assistive tech to workforce automation. We partner with visionary founders and aligned co-investors to back scalable, inclusive solutions. Mobility Solutions: Tech that expands access and independence - from personal transportation to adaptive infrastructure. Future of Work: Solutions to support access to work for everybody Assistive & Care Technology: Innovations that improve life for people with disabilities, aging populations, or mental health challenges. Community & Connection: Platforms that reduce isolation, combat labor shortages, and foster social participation. Health & Wellness: Solutions that improve physical and mental well-being through prevention, care, and everyday health.

Our strategy leverages an extensive hospital system and health plan network of relationships to target attractive market segments, to identify and evaluate investment opportunities, and to support the growth of our portfolio companies. Current Areas of Focus:Administrative Automation Behavioral Health: HCIT & Services Data Security Digital Therapeutics Genomics: Applications & Analytics Patient Safety & Risk Monitoring Pharma Data & Analytics Platforms Social Determinants of Health Virtual Care Models Women’s Health: HCIT & Services

We invest in unstoppable founders who have the ability to understand today the problems of tomorrow, defining the future of consumption with a clear mission: upgrading our lives. We admire brands that encourage responsible innovation, diversity, transparency and positive change. We guide founders by providing top operational and strategic support, working side by side in true partnership. Our community and expert network is endless, and we make sure you get what you need. We understand the power harnessed by the brands that modern consumers love: a compelling mix of seamless products & experiences, engaging content and a true sense of belonging, all enabled by data and technology. We specialise in the intersection of Community, Branding, Innovation and Technology. And we do this by combining art, science and intuition, secretly noticing details that no one else sees, operating with purpose and empathy, with the aim to build a more human digital-lifestyle future. We back globally ambitious founders operating across Europe, UK and the US; helping accelerate their growth via our unique access to major markets, including Asia. We promote investments leading/co-leading Series A (+/-) and co-investing in later-stage rounds.

We build and invest in companies that positively impact human health with smart solutions, breakthrough science and technology. Our focus is on innovation in digital healthcare, connected medical devices, and life sciences We focus on therapeutic and preventive technology solutions addressing unmet needs in some of the most vulnerable segments of society: women, children and the elderly. Digital transformation will continue to shape our lives and has the potential to transform care. We aim to build and support Digital Health & Life Sciences companies working to make healthcare smarter, using data to improve care and outcomes, and reinventing the patient journey. Our vision for the future of healthcare guides our investment strategy. A data driven digital transformation will shape the future of healthcare. The traditional biopharma model will evolve into an integrated model, where prevention, precision cure, and care management will coexist in a highly personalized patient-centric solution. Our goal is to support the creation of life transforming care products and therapies. We believe the future of healthcare lies in supporting the next-generation of founders and teams who will lead us there. What do we look for?Innovation and groundbreaking opportunities in our sectors of focus: digital health, life sciences, tech-enabled care delivery, and connected devices Innovative treatments for Central Nervous System (CNS) disorders, in particular neurodevelopmental disorders, mental health and epilepsy Founders and teams with domain expertise who seek collaborative investment partners Investments that span development and commercial phases, with a focus on early stage opportunities (Pre-Seed to Series A). Our investment approachOur investment approach combines direct investments in early-stage companies with venture creation from bold ideas in global innovation hubs Our goal is to enable talented entrepreneurs to scale more quickly and effectively through access to our capital, enterprise capabilities and consumer touchpoints, while offering expertise and insights from Angelini’s unique perspective. We invest primarily across Europe, North America and Israel, recognizing that healthcare technology innovation is occurring in many cities around the world. We have committed €300M for investments and company creation in digital health and life sciences. What do we commit to you?Active and involved healthcare investors who operate with integrity, approachability, and transparency A team of passionate healthcare and venture capital experts diverse in demographic and experience A track record of success and experience navigating the ups and downs of early-stage company building Access to a world-class advisory board to leverage C-level experience, expertise, and leadership in healthcare

We believe that these solutions cover a wide spectrum that includes the optimization of physical, mental, social and financial wellness, serving as the core components that will undergird the conscious, communal shift toward a healthier future. Our primary goal is to empower passionate founders who develop innovative ideas that impact all bodies. We're investing in more than just potential, we’re doubling down on the endless realm of human potential. With efficiency in mind, we like to spend our first meeting getting to understand the founder(s) first. Your first conversation may be with one of our Partners or investors. Each member of our team has a voice and it's respected at the table. After that conversation, we huddle to connect the dots, reflect on your story and think. From there we spend time with information shared and will come back with deeper questions that move the relationship forward. These are not questions to occupy your inbox, but questions formulated on our path to deep conviction. HEALTH Healthcare has reached an inflection point. The landscape is rapidly shifting towards value based care, deep personalization, and an endless appetite for connected data that will forever change the way we communicate with health providers, our families and ourselves. WELLNESS The wellness industry is a $4.5T opportunity, as more consumers seek to reduce their healthcare costs while exploring ways to be healthier and happier across physical, mental, social and spiritual dimensions of their lives. We seek innovative companies using technology to deliver benefits that are meaningful, measurable and scalable. TECHNOLOGY Software will continue to impact the world in ways never imagined. We're firm in our belief of embracing technology as the conduit for optimization. Innovative applications and connected hardware will continue to change behaviors, augment processes and provide stable infrastructure to advance the world's capabilities. STAGE & CHECK SIZE Our funding decisions are made by consensus. There will always be an internal deal champion that will serve as your lead investor. We practice a rigorous diligence process that can sometimes be complex or very swift - but we typically are able to gather the information we need in 2 weeks or less, once we've aligned on our potential partnership. It's our obligation to earn your trust and build on our relationship. To that end we run a transparent process, with no "GOTCHA" moments. We will work closely with the founder(s) to determine our entry point that makes sense. We are hands-on investors, we set out with a 90 day action plan to be additive at the outset. Stage: Seed-Series A Size: $500K-$3MM Fund Size: $50M As the capital landscape continues to evolve, we remain flexible to understand the specific needs of the entrepreneur. We have a framework that directs our investing. In order for us to spend dedicated time with our founders, we target 6-8 investments per year. These companies typically have a working prototype product getting user feedback or generating revenue, approaching product market fit. On occasion, we invest in exceptional teams at the concept level.

Pivotal Ventures (“Pivotal”) is an investment and incubation company created by Melinda French Gates. We partner, invest, and advocate to remove barriers that hold people back, concentrating on areas where progress and opportunity have stalled for millions of Americans. The pursuit of a more equal and equitable United States - not just for some of us, but for everyone - is what drives us forward. It's the why behind every problem we tackle. We approach partnership with big ambitions and open minds, embracing what’s already working and innovating beyond traditional philanthropy. Some areas we focus on: women in technology and innovation; Women in public office; women and girls of color; adolescent mental health; paid family and medical leave; and caregiving. Inspired by our founder, we reach across communities and sectors to bring together changemakers who can scale up proven ideas and catalyze new ones. We learn from their experiences, amplify their resources, then step back so they can lead. Our impatience with the status quo is fueled by an optimism that progress is always possible.